PLx Pharma, Inc.
(NASDAQ : PLXP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-2.44%21.211.8%$146.61m
MDCOMedicines Company
-1.73%36.3621.8%$74.26m
JAZZJazz Pharmaceuticals Plc
0.01%136.632.3%$65.60m
ARQLArQule, Inc.
-2.83%10.320.7%$65.49m
PRGOPerrigo Co. Plc
-0.53%50.116.8%$59.84m
SAGESAGE Therapeutics, Inc.
-0.69%179.018.7%$53.27m
UTHRUnited Therapeutics Corporation
-0.18%75.7914.3%$48.82m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.57%161.976.2%$43.72m
HZNPHorizon Pharma plc
-1.11%23.586.7%$42.35m
CTLTCatalent Inc
-0.41%53.522.4%$39.52m
ICLRICON Plc
0.28%150.544.1%$34.24m
ICPTIntercept Pharmaceuticals, Inc.
0.11%68.7618.6%$33.12m
AXSMAxsome Therapeutics, Inc.
-2.03%25.052.1%$23.87m
PTLAPortola Pharmaceuticals, Inc.
-1.32%25.347.5%$22.55m
ENDPEndo International Plc
-2.44%3.608.8%$19.86m

Company Profile

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development of clinically validated and patent-protected PLxGuard delivery system. Its products include Vazalore 325 mg and PL1200 Ibuprofen 200 mg. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Houston, TX.